CRIS Current Research Information System

RIZZELLO, FERNANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.126
EU - Europa 5.749
AS - Asia 2.049
AF - Africa 433
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 16.388
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.058
GB - Regno Unito 1.525
IT - Italia 1.158
SE - Svezia 768
CN - Cina 735
DE - Germania 723
VN - Vietnam 613
UA - Ucraina 335
IN - India 331
IE - Irlanda 290
FR - Francia 232
RU - Federazione Russa 203
SG - Singapore 176
TG - Togo 154
ZA - Sudafrica 122
CH - Svizzera 110
EE - Estonia 108
BG - Bulgaria 107
CI - Costa d'Avorio 106
JO - Giordania 103
BE - Belgio 53
FI - Finlandia 39
HN - Honduras 36
SC - Seychelles 31
NL - Olanda 23
GR - Grecia 20
IR - Iran 20
JP - Giappone 19
NG - Nigeria 17
BZ - Belize 16
CA - Canada 16
PL - Polonia 16
CL - Cile 9
CZ - Repubblica Ceca 9
ES - Italia 9
BR - Brasile 7
HK - Hong Kong 7
KR - Corea 6
RO - Romania 6
UZ - Uzbekistan 6
AU - Australia 5
EU - Europa 5
LB - Libano 5
PH - Filippine 5
HR - Croazia 4
PT - Portogallo 4
TR - Turchia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
SA - Arabia Saudita 3
TW - Taiwan 3
AR - Argentina 2
AT - Austria 2
DK - Danimarca 2
IL - Israele 2
PK - Pakistan 2
QA - Qatar 2
AF - Afghanistan, Repubblica islamica di 1
BD - Bangladesh 1
DZ - Algeria 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
RS - Serbia 1
TH - Thailandia 1
Totale 16.388
Salva come PNG Salva come JPEG
Città #
Southend 1.352
Fairfield 1.056
Chandler 842
Ashburn 730
Woodbridge 530
Houston 485
Wilmington 457
Seattle 425
Princeton 387
Cambridge 346
Dong Ket 326
Ann Arbor 325
Dublin 290
Bologna 208
Jacksonville 174
Nanjing 157
Lomé 154
Westminster 148
Singapore 124
Berlin 123
Padova 123
Sofia 107
Abidjan 106
Amman 103
San Diego 99
Bern 92
Beijing 82
New York 72
Shenyang 70
Milan 66
Saint Petersburg 66
Turin 66
Jinan 58
Hebei 50
Changsha 47
Redwood City 44
Mülheim 43
Medford 40
Redmond 40
Boardman 36
Bremen 35
Brussels 35
Phoenix 35
Nanchang 34
Dearborn 33
Henderson 33
Rome 33
Des Moines 32
Helsinki 31
Saint Louis 27
Centro 26
Falls Church 26
Florence 26
Jiaxing 24
Mahé 24
Tianjin 24
Los Angeles 23
Norwalk 23
Washington 22
Brierley Hill 21
Haikou 20
Olalla 18
Abeokuta 16
Belize City 16
Boydton 16
Taiyuan 16
Taizhou 16
Atlanta 15
Guangzhou 15
Leawood 15
Pune 15
Hangzhou 14
Pesaro 14
Zhengzhou 14
Frankfurt am Main 13
Ningbo 13
Tokyo 13
San Venanzo 12
Toronto 12
Buffalo 11
Castel Maggiore 11
London 11
Modena 11
Verona 11
Bühl 10
Capaccio 10
Ferrara 10
Provo 10
Amsterdam 9
Cervia 9
Monmouth Junction 9
San Pedro Sula 9
Chelyabinsk 8
Costa Mesa 8
Kunming 8
Mantova 8
Frankfurt Am Main 7
Fremont 7
Fuzhou 7
Hefei 7
Totale 11.090
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 510
Ulcerative Colitis 203
COVID-19 in IBD: The experience of a single tertiary IBD center 194
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. 187
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 176
Adalimumab in active ulcerative colitis: a "real-life" observational study. 165
Adult attachment and early parental experiences in patients with Crohn’s Disease 164
Attachment and quality of life in patients with inflammatory bowel disease 154
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 151
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 151
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 146
Infliximab in the treatment of Crohn's disease 145
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 145
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 144
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 143
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 141
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management 136
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 134
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 134
Clinical course of microscopic colitis in a single-center cohort study 132
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 132
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 131
Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis 130
Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice 129
Management and treatment of distal ulcerative colitis 129
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 128
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 127
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 124
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 124
Cyclooxygenase-2 Silencing for the Treatment of Colitis: A Combined In Vivo Strategy Based on RNA Interference and Engineered Escherichia Coli 124
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 123
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 123
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 123
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study 121
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 121
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 120
High-dose probiotics for the treatment of active pouchitis 118
Medical treatment and management of severe ulcerative colitis 118
Antibiotics and probiotics in treatment of inflammatory bowel disease 118
Sympathetic hyperactivity in patients with ulcerative colitis. 117
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 115
Antimicrobials in the management of inflammatory bowel disease 115
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 114
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 112
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells 112
Implications of antioxidant enzymes in human gastric neoplasms 112
Review article: aminosalicylates for distal colitis 111
Oral budesonide in the treatment of chronic refractory pouchitis. 111
CT-guided percutaneous pelvic abscess drainage in Crohn's disease 111
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 111
Prevalence and effectiveness of psychiatric treatments for patients with IBD: A systematic literature review 111
P325 Risk factors for lymph node involvement in patients undergoing ileal pouch-anal anastomosis for ulcerative colitis complicated by colorectal cancer in the biological years 110
P151 Characteristics of presentation and risk factors for early recurrence after strictureplasty for Crohn’s disease of the small bowel in the biological era 110
Role of conventional therapies in the era of biological treatment in Crohn's disease. 110
MANAGEMENT OF POUCHITIS 110
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 109
Oral beclomethasone dipropionate in chronic refractory pouchitis 108
Randomized controlled trials in pouchitis 108
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 108
Which therapies are advisable in pouchitis? 106
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 106
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease 105
Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis 105
Problematic proctitis and distal colitis 105
The role of Budesonide-MMX in active ulcerative colitis. 104
Transabdominal salvage surgery after pouch failure in a tertiary center: a case-matched study 104
Probiotics, Prebiotics, and Antibiotics in IBD 101
Probiotics in IBD: A critical review 101
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 101
Role of Biologics in refractory pouchitis 100
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 100
Parental Bonding and Inflammatory Bowel Disease 100
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 100
Probiotic therapy to prevent pouchitis onset 99
Pre-pouch ileitis 98
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 98
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 98
Management of inflammatory bowel disease: does rifaximin offer any promises 97
Local injection of adalimumab for perianal Crohn's disease: better than infliximab? 97
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 96
Predictors of early recurrence after strictureplasty for Crohn's disease of the small bowel during the years of biologics 96
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 95
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 95
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study. 94
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 94
Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study 92
Rescue therapy: ciclosporin or infliximab? 91
OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS 90
DOP62 Morbidity after primary ileocecal resection for Crohn’s disease in the years of biologics: Lesson learned over 631 patients exclusively treated in a tertiary centre 90
Highly concentrated probiotics prevent pouchitis onset 89
Parvovirus B19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease 89
Selective cyclooxygenase-2 (COX-2) silencing mediated by engineered Escherichia coli and RNA Interference induces anti-tumour effects in human colon cancer cells 88
The role of antibiotics and probiotics in pouchitis 88
Implications of the westernized diet in the onset and progression of IBD 88
Risk of permanent stoma in extensive Crohn's colitis: The impact of biological drugs 87
Probiotics and barrier function in colitis 87
Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign 87
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 85
Topical treatment of distal active ulcerative colitis with beclometasone dipropionato or mesalamine: a single-blind randomized controlled trial 84
null 84
Totale 11.957
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.597 0 93 44 262 430 436 502 561 581 308 158 222
2020/20212.793 490 151 80 116 79 150 124 248 297 220 96 742
2021/20223.320 352 93 217 160 295 168 83 196 203 236 820 497
2022/20233.810 400 512 184 462 248 317 103 214 738 105 271 256
2023/20241.226 80 199 109 94 96 290 74 78 36 65 46 59
2024/2025256 248 8 0 0 0 0 0 0 0 0 0 0
Totale 17.074